Ke Cao Selected Research

Ke Cao Research Topics

Disease

66	Neoplasms (Cancer) 04/2024 - 11/2010
13	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2014
12	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 01/2019
11	Inflammation (Inflammations) 04/2022 - 04/2014
11	Melanoma (Melanoma, Malignant) 01/2021 - 01/2015
9	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2009
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 09/2012
8	Carcinoma (Carcinomatosis) 01/2022 - 01/2014
8	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2008
7	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2014
7	Hypoxia (Hypoxemia) 12/2023 - 07/2008
7	Carcinogenesis 09/2023 - 01/2015
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2014
6	Rectal Neoplasms (Rectal Cancer) 03/2024 - 01/2020
6	Insulin Resistance 01/2022 - 03/2013
5	Nasopharyngeal Carcinoma 06/2023 - 01/2014
5	Infections 01/2023 - 01/2015
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2014
4	Obesity 01/2023 - 10/2014
4	Acne Vulgaris 01/2022 - 01/2019
4	Hyperlipidemias (Hyperlipidemia) 11/2020 - 10/2014
3	Cognitive Dysfunction 01/2023 - 10/2014
3	Sepsis (Septicemia) 01/2022 - 01/2017
3	Pneumonia (Pneumonitis) 01/2021 - 01/2015
3	Adenocarcinoma of Lung 01/2020 - 06/2017
3	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 11/2013
2	Fibrosis (Cirrhosis) 11/2023 - 01/2009
2	Colonic Neoplasms (Colon Cancer) 11/2023 - 01/2014
2	Brain Neoplasms (Brain Tumor) 09/2022 - 01/2019
2	Necrosis 01/2022 - 01/2018
2	Skin Diseases (Skin Disease) 01/2022 - 01/2022
2	Pleural Effusion (Pleural Effusions) 08/2021 - 01/2021
2	Nevus (Nevi) 01/2021 - 01/2017
2	Keratoconus 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2015
2	Edema (Dropsy) 01/2021 - 10/2020
2	Lymphatic Metastasis 10/2020 - 04/2016
2	Wounds and Injuries (Trauma) 10/2020 - 09/2018
2	Acute Kidney Injury (Acute Renal Failure) 06/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2014
14	Long Noncoding RNAIBA 10/2023 - 06/2017
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2014
9	MicroRNAs (MicroRNA)IBA 04/2022 - 07/2008
9	LipidsIBA 09/2021 - 02/2012
7	Small Interfering RNA (siRNA)IBA 02/2022 - 01/2014
7	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 07/2018
6	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 01/2014
5	Circular RNAIBA 06/2023 - 04/2018
5	Therapeutic UsesIBA 07/2022 - 06/2014
5	CytokinesIBA 04/2022 - 10/2014
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2016
4	LipopolysaccharidesIBA 07/2022 - 01/2017
4	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2013
4	punicalaginIBA 12/2021 - 10/2014
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2014
4	dihydroceramide desaturaseIBA 10/2020 - 01/2016
4	CeramidesIBA 10/2020 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 11/2017
3	AlbuminsIBA 12/2022 - 06/2020
3	Competitive Endogenous RNAIBA 04/2022 - 11/2020
3	NF-kappa B (NF-kB)IBA 04/2022 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 06/2013
3	EnzymesIBA 01/2022 - 06/2013
3	AntigensIBA 06/2021 - 09/2012
3	Carrier Proteins (Binding Protein)IBA 12/2020 - 01/2015
3	Messenger RNA (mRNA)IBA 12/2020 - 11/2010
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2016
3	CholesterolIBA 01/2019 - 10/2014
2	AMP-Activated Protein KinasesIBA 05/2024 - 09/2015
2	ran-binding protein 2IBA 02/2024 - 07/2021
2	AntioxidantsIBA 01/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 12/2022 - 07/2022
2	Arginine (L-Arginine)FDA Link 12/2022 - 01/2022
2	Trinitrotoluene (TNT)IBA 07/2022 - 01/2022
2	FlavonoidsIBA 03/2022 - 01/2022
2	Serpentine Asbestos (Chrysotile)IBA 02/2022 - 06/2021
2	AcidsIBA 01/2022 - 06/2014
2	6-methyladenineIBA 01/2022 - 01/2021
2	Antisense RNA (Anti-Sense RNA)IBA 12/2021 - 01/2021
2	ResveratrolIBA 09/2021 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2016
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 02/2015
2	Melanins (Melanin)IBA 01/2021 - 01/2016
2	Histones (Histone)IBA 01/2021 - 11/2010
2	CollagenIBA 01/2021 - 01/2017
2	ellagitanninIBA 11/2020 - 09/2015
2	Poloxamer (Poloxamer 407)IBA 11/2020 - 01/2020
2	SphingolipidsIBA 10/2020 - 01/2016
2	RV 538 (PDMP)IBA 01/2020 - 01/2016

Therapy/Procedure

12	Radiotherapy 10/2023 - 02/2013
12	Therapeutics 06/2023 - 01/2017
10	Immunotherapy 12/2023 - 09/2016
8	Drug Therapy (Chemotherapy) 12/2023 - 09/2012
5	Neoadjuvant Therapy 03/2024 - 01/2020
3	Critical Care (Surgical Intensive Care) 07/2022 - 01/2017
2	Hematopoietic Stem Cell Transplantation 10/2023 - 01/2023
2	Ligation 01/2022 - 01/2017
2	Punctures 01/2022 - 01/2017